Oncternal Therapeutics

1 follower


Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.

Industries

Employees

11-50

Links

Org chart

James Breitmeyer
President & CEO

James Breitmeyer

Collapse
Chase Leavitt
General Counsel & Corporate Secretary
Anita Wiseth
Senior Vice President, HR
Mary Breitmeyer
Vp, Technical Operations & Alliance Management

Board & advisors

Bill Larue
Director
Robert Wills
Director
Jeffrey Toretsky
Scientific Advisor
Thomas Kipps
Scientific Advisor